2021.06.24Information
Warning from the European Medicines Agency, based on data from the Safety Assessment Committee on 11 Jun, 2021
At a meeting from June 7th to 10th, the Pharmacovigilance Risk Assessment Committee (PRAC) identified capillary leak syndrome with AstraZeneca’s COVID-19 vaccine as a side effect.
The side effect is observed as a delayed side symptomatology with mRNA vaccines as well.
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 7-10 June 2021
